Answers are grounded in this paper and cite their sources.
With many recent advancements in spasticity treatment, more patients are surviving critical illness and injury but are left with ongoing disability that needs constant treatment. Such treatment will change as the patient's condition evolves. Constant appraisal of treatment efficacy and patient progress is therefore an important component of spasticity management, and physicians need to be familiar with how to troubleshoot treatment regimens when outcomes of that regimen become suboptimal. This module considers how to optimize the use and outcomes of major treatment modalities and provides drug and device maintenance algorithms to guide the treating team.
No takes yet. Share an insight, caveat, or question.
Ketchum et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: